Pembrolizumab Plus Lenvatinib Approved for Endometrial Cancer

The combination was simulataneously approved in Australia and Canada and was the first such action under a new international collaboration.

Source: CancerNetwork - September 17, 2019 Category: Cancer & Oncology Authors: Erin Kayata Source Type: news